Showing results (71-80 of 200) with videos related to
Sort By:
Pageof 20
Nutricion Hospitalaria|June 22, 2014
Antioxidant responses of damiana (Turnera diffusa Willd) to exposure to artificial ultraviolet (UV) radiation in an in vitro model; part ii; UV-B radiationLluvia de Abril Alexandra Soriano-Melgar, Lilia Alcaraz-Meléndez, Lía C Méndez-Rodríguez, et al.Annals of Translational Medicine|November 9, 2017
Dendritic cell therapy in melanomaCarmen Alvarez-Dominguez, Ricardo Calderón-Gonzalez, Hector Terán-Navarro, et al.Oncology Research|April 26, 2014
Phase II study of bevacizumab, capecitabine, and oxaliplatin followed by bevacizumab plus erlotinib as first-line therapy in metastatic colorectal cancerAlberto Muñoz, Carles Pericay, Carlos García-Girón, et al.The Clinical Neuropsychologist|September 28, 2016
Following international trends while subject to past traditions: neuropsychological test use in the Nordic countriesJens Egeland, Marianne Løvstad, Anne Norup, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 5, 2026
SEOM-GEMCAD-TTD clinical guideline for the diagnosis and treatment of esophageal cancer (update 2025)Ana Fernández-Montes, Julia Alcaide, Ana Belén Custodio, et al.International Journal of Colorectal Disease|April 21, 2017
Final analysis of the randomised PEAK trial: overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with metastatic colorectal carcinomaFernando Rivera, Meinolf Karthaus, J Randolph Hecht, et al.The Plant Pathology Journal|November 30, 2021
First Molecular Characterization of Colletotrichum sp. and Fusarium sp. Isolated from Mangrove in Mexico and the Antagonist Effect of Trichoderma harzianum as an Effective Biocontrol AgentMayra I Grano-Maldonado, Rosalio Ramos-Payan, Fernando Rivera-Chaparro, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trialThierry André, Corrado Boni, Matilde Navarro, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2014
PEAK: a randomized, multicenter phase II study of panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated, unresectable, wild-type KRAS exon 2 metastatic colorectal cancerLee S Schwartzberg, Fernando Rivera, Meinolf Karthaus, et al.Theriogenology|December 19, 2020
Feeding yearling Angus bulls low-level ergot daily for 9 weeks decreased serum prolactin concentrations and had subtle effects on sperm end pointsMoveed R Chohan, Brennan J Munro, Vanessa E Cowan, et al.Pageof 20